Venus Medtech (Hangzhou) Inc 2022 AR2
The report highlights Venus Medtech's progress in 2022, including the European commercial launch of its VenusP-Valve, the first self-expanding TPVR product approved under the CE MDR regulations. The company also completed the acquisition of Cardiovalve, expanding its structural heart disease portfolio into mitral and tricuspid valve treatments. Financially, Venus Medtech recorded revenue of RMB 406.5 million, though it experienced a net loss due to impairment provisions related to the Keystone Group. On the ESG front, the company established a three-tier ESG governance structure and achieved its 2022 environmental targets, including obtaining ISO 14001 and ISO 45001 certifications.
Company: Venus Medtech (Hangzhou) Inc
Sector: Health Care
Country: China
Year: 2022
Type: AR2
Pages: 309
Venus Medtech (Hangzhou) Inc
Annual Report
The report highlights Venus Medtech's progress in 2022, including the European commercial launch of its VenusP-Valve, the first self-expanding TPVR product approved under the CE MDR regulations. The company also completed the acquisition of Cardiovalve, expanding its structural heart disease portfolio into mitral and tricuspid valve treatments. Financially, Venus Medtech recorded revenue of RMB 406.5 million, though it experienced a net loss due to impairment provisions related to the Keystone Group. On the ESG front, the company established a three-tier ESG governance structure and achieved its 2022 environmental targets, including obtaining ISO 14001 and ISO 45001 certifications.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Workplace Fatalities
Employees